0001708138-20-000054.txt : 20200511
0001708138-20-000054.hdr.sgml : 20200511
20200511163921
ACCESSION NUMBER: 0001708138-20-000054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200508
FILED AS OF DATE: 20200511
DATE AS OF CHANGE: 20200511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAHL NEIL
CENTRAL INDEX KEY: 0001226689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20865504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-05-08
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001226689
STAHL NEIL
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Research and Development
Common Stock
2020-05-08
4
M
0
12500
52.03
A
23880
D
Common Stock
2020-05-08
4
F
0
7195
560.67
D
16685
D
Common Stock
2020-05-11
4
S
0
312
567.5
D
16373
D
Common Stock
2020-05-11
4
S
0
792
568.71
D
15581
D
Common Stock
2020-05-11
4
S
0
2175
569.39
D
13406
D
Common Stock
2020-05-11
4
S
0
2026
570.28
D
11380
D
Common Stock
5763
I
By 401(k) Plan
Common Stock
7831
I
by 2018 GRAT
Common Stock
13700
I
by 2019 GRAT
Non-Qualified Stock Option (right to buy)
52.03
2020-05-08
4
M
0
12500
0.0
D
2021-12-16
Common Stock
12500
12500
D
Represents volume-weighted average price of sales of 312 shares of Company stock on May 11, 2020 at prices ranging from $567.11 to $567.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price.
Represents volume-weighted average price of sales of 792 shares of Company stock on May 11, 2020 at prices ranging from $568.00 to $568.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,175 shares of Company stock on May 11, 2020 at prices ranging from $569.00 to $569.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,026 shares of Company stock on May 11, 2020 at prices ranging from $570.00 to $570.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price.
With respect to 75,000 underlying shares (of which 12,500 remain outstanding) the option became exercisable on December 31, 2014, based upon the satisfaction by the
company of certain performance criteria during the period ended December 31, 2014.
/s/**Neil Stahl
2020-05-11